{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:51Z","timestamp":1794047451129,"version":"4.8.0"},"reference-count":8,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284292","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T02:31:25Z","timestamp":1700101885000},"page":"1320-1322","source":"Crossref","is-referenced-by-count":3,"title":["In search for cure of multiple myeloma"],"prefix":"10.3324","volume":"109","author":[{"given":"Ralph","family":"W\u00e4sch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"60086","doi-asserted-by":"crossref","unstructured":"Gahrton G, Svensson H, Cavo M. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol. 2001; 113(1):209-216.","DOI":"10.1046\/j.1365-2141.2001.02726.x"},{"key":"60087","doi-asserted-by":"crossref","unstructured":"Greil C, Engelhardt M, Ihorst G. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Haematologica. 2019; 104(2):370-379.","DOI":"10.3324\/haematol.2018.200881"},{"key":"60088","doi-asserted-by":"crossref","unstructured":"Greil C, Engelhardt M, Finke J, W\u00e4sch R. Allogeneic stem cell transplantation in multiple myeloma. Cancers (Basel). 2021; 14(1):55.","DOI":"10.3390\/cancers14010055"},{"key":"60089","doi-asserted-by":"crossref","unstructured":"Maloney DG, Molina AJ, Sahebi F. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood. 2003; 102(9):3447-3454.","DOI":"10.1182\/blood-2002-09-2955"},{"key":"60090","doi-asserted-by":"crossref","unstructured":"Waldschmidt JM, Keller A, Ihorst G. Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I\/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). Haematologica. 2018; 103(10):e473-e479.","DOI":"10.3324\/haematol.2018.189969"},{"key":"60091","doi-asserted-by":"crossref","unstructured":"Dieterle MP, Mostufi-Zadeh-Haghighi G, Kus JW. Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians. Ann Hematol. 2023; 102(12):3639-3641.","DOI":"10.1007\/s00277-023-05451-8"},{"key":"60092","doi-asserted-by":"crossref","unstructured":"Kr\u00f6ger N, Wulf GG, Hegenbart U. Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for patients with multiple myeloma and age <60 years: a prospective phase II-study. Haematologica. 2024; 109(5):1469-1479.","DOI":"10.3324\/haematol.2023.282920"},{"key":"60093","doi-asserted-by":"crossref","unstructured":"Kneppers E, van der Holt B, Kersten MJ. Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial. Blood. 2011; 118(9):2413-2419.","DOI":"10.1182\/blood-2011-04-348292"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284292\/76285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284292\/76923","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11342\/76285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:15Z","timestamp":1794045915000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":8,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284292","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}